Stock Events

Agilent Technologies 

$126.37
397
+$0.24+0.19% Friday 20:00

统计数据

当日最高
126.61
当日最低
125.29
52周最高
155.06
52周最低
96.3
成交量
1,190,437
平均成交量
2,801,999
市值
36.87B
市盈率
29.95
股息收益率
0.75%
股息
0.94

即将到来

股息

0.75%股息收益率
10年增长
9.08%
5年增长
7.03%
3年增长
6.75%
1年增长
3.62%

收益

29May已确认
Q3 2022
Q4 2022
Q1 2023
Q2 2023
Q3 2023
Q4 2023
Q1 2024
1.19
1.3
1.42
1.53
预期每股收益
1.19
实际每股收益
1.22

人们还关注

此列表基于关注A的Stock Events用户的观察列表。这不是投资建议。

竞争者

这个列表是基于最近市场事件的分析。这不是投资建议。

分析师评级

135.55$平均价格目标
最高估值为 $155。
来自过去6个月内的 12 个评级。这不是投资建议。
买入
42%
持有
50%
卖出
8%

关于

Health Technology
Biotechnology
Medical Specialties
Professional, Scientific, and Technical Services
Testing Laboratories
Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps, and measurement technologies. The Diagnostics and Genomics segment provides arrays for DNA mutation detection, genotyping, gene copy number determination, identification of gene rearrangements, DNA methylation profiling, gene expression profiling, next generation sequencing, target enrichment and genetic data management, and interpretation support software; and produces synthesized oligonucleotide. It also offers immunohistochemistry in situ hybridization, and hematoxylin and eosin staining and special staining; consumables, and software for quality control analysis of nucleic acid samples; and reagents for use in turbidimetry and flow cytometry, as well as develops liquid-based pharmacodiagnostics. The Agilent CrossLab segment provides GC and LC columns, sample preparation products, custom chemistries, and laboratory instrument supplies; and startup, operational, training, compliance support, software as a service, asset management, and consultation services. The company markets its products through direct sales, distributors, resellers, manufacturer's representatives, and electronic commerce. Agilent Technologies, Inc. was incorporated in 1999 and is headquartered in Santa Clara, California.
Show more...
首席执行官
Michael McMullen
员工
17600
国家
US
ISIN
US00846U1016
WKN
000929138

上市公司